Researchers have discovered that a modified version of an important immune cell protein could be used to treat Alzheimer’s disease. The study reveals that soluble versions of a protein called TLR5 can reduce the buildup of amyloid plaques in the brains of Alzheimer’s disease model mice and prevent the toxic peptide that forms these plaques from killing neurons.